Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery (Reverse-IT Trial). @BilalHussain294 had a great conversation with @DLBHATTMD at #ACC25 @MountSinaiHeart

Dr. Michael Reardon, TAVI pioneer @HMethodistCV, sat down with Mohanad Hamandi @MayoClinicCV @HamandiMd to discuss the Evolut 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. #ACC25

Dr. Zain Asad and Dr. Hemanth Sanjamala on the Role of Cardio-Oncology i... https://t.co/5irTXEzS9f via @YouTube @ZainAsadCardOnc @OUHealth @ResearchOU @FITsOnTheGo @MayoCVFellows @MayoClinicCV

Dr. Julia Grapsa & Dr. Adriana Mares on Mentorship, Sponsorship, and Adv... https://t.co/sY4BKHIJ0b via @YouTube @JGrapsa @AdrianaCMares @amanpreet_wasir @FITsOnTheGo @ACCinTouch @MayoCVFellows @MayoClinicCV

Dr. Julia Grapsa and Dr. Vikash Jaiswal on AI in Cardiovascular Imaging https://t.co/ZhgP6s1JbS via @YouTube @JGrapsa @VikashJaiswalMD @BrighamWomens @FITsOnTheGo @MayoCVFellows @MayoClinicCV @AhAminMD @HamandiMd

Dr. Amish Raval & Dr. Apurva Challa on Autologous stem cell research https://t.co/9RjahpdClG via @YouTube @ApurvaChalla @FITsOnTheGo @UWMadison @MayoCVFellows @MayoClinicCV @AhAminMD @HamandiMd

Dr. Marc Bonaca and Dr. Shiavax Rao on Primary Results of the STRIDE Trial https://t.co/SJg2XjXVWd via @YouTube @MarcBonaca @ShiavaxJRaoMD @CUSystem @MayoCVFellows @FITsOnTheGo @MayoClinicCV @AhAminMD @AdrianaCMares @Gamarra_NN @amanpreet_wasir @ACCinTouch

Dr. Sebastian Kelle and Dr. Prem Patel on Mobile CMR for HF Detection https://t.co/ocqON27ZFM via @YouTube @SKelle_Berlin @Prem_N_Patel @FITsOnTheGo @MayoCVFellows @MayoClinicCV @AdrianaCMares @amanpreet_wasir @Gamarra_NN @AhAminMD @HamandiMd

Dr. Rachita Navara and Dr. Douglas Corsi on Innovation, Electrophysiolog... https://t.co/hmqm0ZpdWT via @YouTube @DrRachitaEP @corsi_douglas @FITsOnTheGo @MayoCVFellows @MayoClinicCV @AhAminMD @HamandiMd @UCSFHospitals @RWJMS

Dr. Jonathan Kim, Dr. Aaron Baggish & Dr. Kaitlyn McSurdy on Cardiac Arr... https://t.co/axKpWH8vLR via @YouTube @jonathankimmd @kaitlyn_mcsurdy @emoryheart @PittCardiology @FITsOnTheGo @MayoCVFellows @MayoClinicCV @AhAminMD @HamandiMd @amanpreet_wasir @AdrianaCMares @Gamarra_NN

Dr. Antonius Büscher & Dr. Neel Patel on AI-Based ECG for Risk Stratifi... https://t.co/KV6Xgb5ueP via @YouTube @NPatelMD @FITsOnTheGo @MayoCVFellows @MayoClinicCV @HamandiMd @AhAminMD

Dr. Sourbha Dani and Dr. Norma Gamarra on Passion and History behind the... https://t.co/H7BpJ19Aj7 via @YouTube @SaurabhSDani @bethisraellahey @Gamarra_NN @ACCinTouch @FITsOnTheGo @MayoCVFellows @MayoClinicCV @HamandiMd @AhAminMD @amanpreet_wasir @AdrianaCMares #FITJeopardy

5-year outcomes are in! At #ACC25, we caught up with Dr. Michael Reardon to discuss the Evolut Low-Risk TAVR vs SAVR trial. What does the long-term data reveal about mortality and stroke in low-risk patients? @HMethodistCV @HamandiMd @MayoClinicCV @MayoCVFellows

The ALPACA Phase 2 trial studied Lepodisiran, a small-interfering RNA, with results extending out to 540 days. Extended durability, promising reductions. We had the absolute pleasure to talk with Dr Nissen from @ClevelandClinic at #ACC25 @mohossainmd @RutgersIMRes

Clopidogrel vs Aspirin for long-term monotherapy after PCI in high ischemic risk patients? Big implications for long-term care. Full interview now on YouTube | FITsOnTheGo @mySMC @SanjanaNagraj #ACC25 @MayoClinicCV

Full circle at #ACC25! We caught up with Dr. @jeffreygeske, one of the original founders (alongside Dr. Michael Cullen) of @FITsOnTheGo An inspiring convo on how the initiative started—and how YOU can get involved in #MedEd Shoutout to @MayoCVFellows for keeping the spirit alive

Meet the leadership team behind @FITsOnTheGo initiative of Mayo Clinic at ACC25. @MayoCVFellows @AhAminMD @SidAgarwalMBBS @HamandiMd

FIT Jeopardy is one of those activities you can’t miss at ACC conference. The spirit of competition, learning, and camaraderie among the fellows is truly inspiring. Today, I had the privilege of interviewing the heart and mind behind this project, Dr. @SaurabhSDani, for

Lorundrostat—a new player in hypertension management? This aldosterone synthase inhibitor showed promising efficacy in patients with uncontrolled hypertension despite a standardized regimen. We covered it at #ACC25—don’t miss the science. @ljlaffin @ClevelandClinic @DoadJagroop

Can Digifab prevent post-op AKI in high-risk CABG patients? Watch our interview with Dr Stephen Gottlieb from University of Maryland @RonakBharucha @UpstateCardiol1 @MayoClinicCV #ACC25